Adalimumab-Adbm injection: Boehringer Ingelheim Pharmaceuticals discontinued two presentations of Cyltezo, its biosimilar to ... presentations of this ADHD medication due to a shortage of active ...
Advertisement But at the same time, prescriptions for other types of stimulant drugs used in ADHD treatment increased, according to study results. "Our findings suggest that the Adderall shortage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results